Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, Milgrom E, Kuttenn F, Misrahi M
INSERM U. 135 Hormones Gènes et Reproduction and Laboratoire d'Hormonologie et Biologie Moléculaire, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, et Institut Fédératif de Recherche IFR 21, 94275 Le Kremlin Bicêtre, France.
J Clin Invest. 1998 Oct 1;102(7):1352-9. doi: 10.1172/JCI3795.
A single natural loss of function mutation of the follicle stimulating hormone receptor (FSHR) has been described to date. Present in the Finnish population it markedly impairs receptor function, blocking follicle development at the primary stage and presenting as primary amenorrhea with atrophic ovaries. When Western European women with this phenotype were examined for FSHR mutations the result was negative, suggesting that other etiologies corresponding to this clinical pattern are markedly more frequent. We now describe a novel phenotype related to mutations provoking a partial loss of function of the FSHR. A woman with secondary amenorrhea had very high plasma gonadotropin concentrations (especially FSH), contrasting with normal sized ovaries and antral follicles up to 5 mm at ultrasonography. Histological and immunohistochemical examination of the ovaries showed normal follicular development up to the small antral stage and a disruption at further stages. The patient was found to carry compound heterozygotic mutations of the FSHR gene: Ile160Thr and Arg573Cys substitutions located, respectively, in the extracellular domain and in the third intracellular loop of the receptor. The mutated receptors, when expressed in COS-7 cells, showed partial functional impairment, consistent with the clinical and histological observations: the first mutation impaired cell surface expression and the second altered signal transduction of the receptor. This observation suggests that a limited FSH effect is sufficient to promote follicular growth up to the small antral stage. Further development necessitates strong FSH stimulation. The contrast between very high FSH levels and normal sized ovaries with antral follicles may thus be characteristic of such patients.
迄今为止,已报道了一例促卵泡激素受体(FSHR)的自然功能丧失性突变。该突变存在于芬兰人群中,显著损害受体功能,在初级阶段阻断卵泡发育,表现为原发性闭经伴卵巢萎缩。对具有这种表型的西欧女性进行FSHR突变检测时,结果为阴性,这表明与这种临床模式相对应的其他病因更为常见。我们现在描述一种与导致FSHR部分功能丧失的突变相关的新表型。一名继发性闭经的女性血浆促性腺激素浓度非常高(尤其是FSH),与之形成对比的是,其卵巢大小正常,超声检查显示窦状卵泡直径达5mm。对卵巢进行组织学和免疫组织化学检查发现,卵泡发育直至小窦状卵泡阶段均正常,但在后续阶段出现破坏。该患者被发现携带FSHR基因的复合杂合突变:Ile160Thr和Arg573Cys替换,分别位于受体的细胞外结构域和第三个细胞内环。当在COS-7细胞中表达时,突变受体显示出部分功能损害,这与临床和组织学观察结果一致:第一个突变损害细胞表面表达,第二个突变改变受体的信号转导。这一观察结果表明,有限的FSH作用足以促进卵泡生长至小窦状卵泡阶段。进一步的发育需要强烈的FSH刺激。因此,FSH水平非常高与具有窦状卵泡的正常大小卵巢之间的差异可能是这类患者的特征。